Integrated Quantitative Transcriptome Maps of Human Trisomy 21 Tissues and Cells

被引:35
作者
Pelleri, Maria Chiara [1 ]
Cattani, Chiara [1 ]
Vitale, Lorenza [1 ]
Antonaros, Francesca [1 ]
Strippoli, Pierluigi [1 ]
Locatelli, Chiara [2 ]
Cocchi, Guido [3 ]
Piovesan, Allison [1 ]
Caracausi, Maria [1 ]
机构
[1] Univ Bologna, Dept Expt Diagnost & Specialty Med, Unit Histol Embryol & Appl Biol, Bologna, Italy
[2] St Orsola Malpighi Polyclin, Neonatol Unit, Bologna, Italy
[3] Univ Bologna, Neonatol Unit, Dept Med & Surg Sci, St Orsola Malpighi Polyclin, Bologna, Italy
关键词
integrated transcriptome map; meta-analysis; human chromosome 21; trisomy; 21; Down syndrome; HUMAN-CHROMOSOME; 21; DOWN-SYNDROME; MICROARRAY DATA; DOSAGE IMBALANCE; EXPRESSION DATA; GENOME; BRAIN; SEQUENCE; IDENTIFICATION; METAANALYSIS;
D O I
10.3389/fgene.2018.00125
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Down syndrome (DS) is due to the presence of an extra full or partial chromosome 21 (Hsa21). The identification of genes contributing to DS pathogenesis could be the key to any rational therapy of the associated intellectual disability. We aim at generating quantitative transcriptome maps in DS integrating all gene expression profile datasets available for any cell type or tissue, to obtain a complete model of the transcriptome in terms of both expression values for each gene and segmental trend of gene expression along each chromosome. We used the TRAM (Transcriptome Mapper) software for this meta-analysis, comparing transcript expression levels and profiles between DS and normal brain, lymphoblastoid cell lines, blood cells, fibroblasts, thymus and induced pluripotent stem cells, respectively. TRAM combined, normalized, and integrated datasets from different sources and across diverse experimental platforms. The main output was a linear expression value that may be used as a reference for each of up to 37,181 mapped transcripts analyzed, related to both known genes and expression sequence tag (EST) clusters. An independent example in vitro validation of fibroblast transcriptome map data was performed through "Real-Time" reverse transcription polymerise chain reaction showing an excellent correlation coefficient (r = 0.93, p < 0.0001) with data obtained in silico. The availability of linear expression values for each gene allowed the testing of the gene dosage hypothesis of the expected 3:2 DS/normal ratio for Hsa21 as well as other human genes in DS, in addition to listing genes differentially expressed with statistical significance. Although a fraction of Hsa21 genes escapes dosage effects, Hsa21 genes are selectively over-expressed in DS samples compared to genes from other chromosomes, reflecting a decisive role in the pathogenesis of the syndrome. Finally, the analysis of chromosomal segments reveals a high prevalence of Hsa21 over-expressed segments over the other genomic regions, suggesting, in particular, a specific region on Hsa21 that appears to be frequently over-expressed (21q22). Our complete datasets are released as a new framework to investigate transcription in DS for individual genes as well as chromosomal segments in different cell types and tissues.
引用
收藏
页数:15
相关论文
共 61 条
[1]   Characterization of the Bex gene family in humans, mice, and rats [J].
Alvarez, E ;
Zhou, WB ;
Witta, SE ;
Freed, CR .
GENE, 2005, 357 (01) :18-28
[2]   Chromosome 21: from sequence to applications [J].
Antonarakis, SE .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2001, 11 (03) :241-246
[3]   Down syndrome and the complexity of genome dosage imbalance [J].
Antonarakis, Stylianos E. .
NATURE REVIEWS GENETICS, 2017, 18 (03) :147-163
[4]   The alliance between genetic biobanks and patient organisations: the experience of the telethon network of genetic biobanks [J].
Baldo, Chiara ;
Casareto, Lorena ;
Renieri, Alessandra ;
Merla, Giuseppe ;
Garavaglia, Barbara ;
Goldwurm, Stefano ;
Pegoraro, Elena ;
Moggio, Maurizio ;
Mora, Marina ;
Politano, Luisa ;
Sangiorgi, Luca ;
Mazzotti, Raffaella ;
Viotti, Valeria ;
Meloni, Ilaria ;
Pellico, Maria Teresa ;
Barzaghi, Chiara ;
Wang, Chiuhui Mary ;
Monaco, Lucia ;
Filocamo, Mirella .
ORPHANET JOURNAL OF RARE DISEASES, 2016, 11 :1-8
[5]   Gene expression omnibus: Microarray data storage, submission, retrieval, and analysis [J].
Barrett, Tanya ;
Edgar, Ron .
DNA MICROARRAYS, PART B: DATABASES AND STATISTICS, 2006, 411 :352-369
[6]   Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9 [J].
Bauer, Daniel E. ;
Canver, Matthew C. ;
Orkin, Stuart H. .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2015, (95)
[7]   DENDRITIC ATROPHY IN CHILDREN WITH DOWNS-SYNDROME [J].
BECKER, LE ;
ARMSTRONG, DL ;
CHAN, F .
ANNALS OF NEUROLOGY, 1986, 20 (04) :520-526
[8]   Integration-Free Induced Pluripotent Stem Cells Model Genetic and Neural Developmental Features of Down Syndrome Etiology [J].
Briggs, James A. ;
Sun, Jane ;
Shepherd, Jill ;
Ovchinnikov, Dmitry A. ;
Chung, Tung-Liang ;
Nayler, Sam P. ;
Kao, Li-Pin ;
Morrow, Carl A. ;
Thakar, Nilay Y. ;
Soo, Set-Yen ;
Peura, Teija ;
Grimmond, Sean ;
Wolvetang, Ernst J. .
STEM CELLS, 2013, 31 (03) :467-478
[9]   The European Bioinformatics Institute's data resources 2014 [J].
Brooksbank, Catherine ;
Bergman, Mary Todd ;
Apweiler, Rolf ;
Birney, Ewan ;
Thornton, Janet .
NUCLEIC ACIDS RESEARCH, 2014, 42 (D1) :D18-D25
[10]   Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism [J].
Caracausi, Maria ;
Ghini, Veronica ;
Locatelli, Chiara ;
Mericio, Martina ;
Piovesan, Allison ;
Antonaros, Francesca ;
Pelleri, Maria Chiara ;
Vitale, Lorenza ;
Vacca, Rosa Anna ;
Bedetti, Federica ;
Mimmi, Maria Chiara ;
Luchinat, Claudio ;
Turano, Paola ;
Strippoli, Pierluigi ;
Cocchi, Guido .
SCIENTIFIC REPORTS, 2018, 8